This page shows the latest Nuplazid news and features for those working in and with pharma, biotech and healthcare.
Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug. Concludes Acadia Pharmaceuticals’ drug provides ‘ modest but meaningful’ benefits. ... Some atypical antipsychotic medicines are used to treat more advanced cases of PDP but -
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.”. ... I look forward to leading the team in advancing the promising development programmes with Nuplazid.".
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...